ARCHIVES

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

This article is from The Cancer Letter archive.

Vol. 26 No. 25 | June 23, 2000

Download PDF Visit The Full Archive

Related Articles

Minnesota Study Aimed At Finding Final Answer On Hemoccult Screening

July 24, 1987

NCI-Approved Trials Listed

April 28, 2006

NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent.

February 23, 2001

Fisher, Bonadonna, Croce, Hanafusa Win GAM Cancer Prizes

June 11, 1993

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

In Brief: Bailes Succeeds Lichor As ASCO President; Einhorn Is President-Elect; Durant Honored

May 21, 1999